SCHEMBL3629040

SCHEMBL3629040

Oc1ccc(Oc2ccc(C3(c4ccc(Oc5ccc(O)cc5)cc4)c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.53
NR1H2 P55055 1/20 0.53
BAX Q07812 1/20 0.53
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
OPRK1 P41145 1/20 0.52
ESR1 P03372 3/20 0.50
ESR2 Q92731 3/20 0.50
GPR55 Q9Y2T6 2/20 0.44
CHRM2 P08172 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
KCNH2 Q12809 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
TYMS P04818 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22651766 1.00 LTA4H (0.53) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL16902923 1.00 LTA4H (0.53) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL20960622 0.97 LTA4H (0.60) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL19901312 0.92 ESR1 (0.49) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL20976008 0.92 LTA4H (0.50) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL21729799 0.89 HSP90AA1 (0.44) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL45826 0.89 MEN1 (0.63) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL900116 0.89 MEN1 (0.63) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL29365596 0.89 MEN1 (0.63) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL15691572 0.89 MEN1 (0.63) MEN1KMT2ALMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212614-B1 PROCESS FOR MAKING BENZOXAZINES CYTEC IND INC (US) 2019-05-01 EP disclosed
EP-3456709-A1 BENZOXAZINE-BASED MONOMER FOR THERMOSETTING RESINS Cytec Industries Inc. (US) 2019-03-20 EP disclosed
US-10227313-B2 Process for making benzoxazines CYTEC INDUSTRIES INC. (US) 2019-03-12 US disclosed
US-20180127387-A1 PROCESS FOR MAKING BENZOXAZINES CYTEC INDUSTRIES INC. (US) 2018-05-10 US disclosed
US-20180127387-A1 PROCESS FOR MAKING BENZOXAZINES CYTEC INDUSTRIES INC. (US) 2018-05-10 US disclosed
US-9902706-B2 Process for making benzoxazines CYTEC INDUSTRIES INC. (US) 2018-02-27 US disclosed
US-20160115139-A1 PROCESS FOR MAKING BENZOXAZINES CYTEC INDUSTRIES INC. (US) 2016-04-28 US disclosed
US-20160115139-A1 PROCESS FOR MAKING BENZOXAZINES CYTEC INDUSTRIES INC. (US) 2016-04-28 US disclosed
US-7811467-B2 Optical film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-10-12 US disclosed
US-20070298191-A1 Optical Film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127387-A1 PROCESS FOR MAKING BENZOXAZINES XDH, AFF1, TYR LTA4H 3741/4885NR1H2 977/4885BAX 435/4885
US-10227313-B2 Process for making benzoxazines XDH, AFF1, TYR LTA4H 3741/4885NR1H2 977/4885BAX 435/4885
US-20160115139-A1 PROCESS FOR MAKING BENZOXAZINES XDH, AFF1, TYR LTA4H 3741/4885NR1H2 977/4885BAX 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.